27871881|t|Targeting brain and peripheral plasticity of the lipidome in acute kainic acid - induced epileptic seizures in mice via quantitative mass spectrometry
27871881|a|Epilepsy is a highly common chronic neurological disorder, manifested in many different types, affecting ~1% of the worldwide human population. The molecular mechanisms of epileptogenesis have not yet been clarified, and pharmacoresistance exhibited by 30-40% of epilepsy patients remains a major obstacle in medical care. Growing evidence indicates a role of lipid signalling pathways in epileptogenesis, thus lipid signals emerge as potential biomarkers for the onset and evolving course of the epileptic disorder, as well as potential therapeutic agents and targets. For this purpose, we applied a lipidomic strategy to unravel lipid alterations in brain regions, periphery tissues and plasma that are specific for acute epileptic seizures in mice at 1h after seizure induction by systemic kainic acid injection as compared to vehicle controls. Specifically, levels of (i) selected phospholipids and sphingomyelins, (ii) the endocannabinoids anandamide (AEA) and 2-arachidonoyl glycerol (2-AG), and the endocannabinoid -related compounds oleoylethanolamide (OEA) and palmitoylethanolamide (PEA), (iii) arachidonic acid (AA), (iv) selected eicosanoids, and (v) fatty acyl content of lipidome were determined in pulverized tissues from six brain regions of kainic acid induced epileptic seizure models and vehicle controls: hypothalamus, hippocampus, thalamus, striatum, cerebellum and cerebral cortex, and from peripheral organs, such as heart and lungs, and in plasma. Alterations in lipid levels after acute epileptic seizures as compared to non-seizure controls were found to be brain region - and periphery tissue - specific, including specific plasma lipid correlates, highlighting their value as marker candidates in translational research studies, and/or drug discovery and response monitoring.
27871881	10	15	brain	T017	UMLS:C0006104
27871881	20	41	peripheral plasticity	T038	UMLS:C0027880
27871881	49	57	lipidome	T103	UMLS:C0023779
27871881	67	78	kainic acid	T103	UMLS:C0022471
27871881	89	107	epileptic seizures	T038	UMLS:C0014544
27871881	111	115	mice	T204	UMLS:C0025929
27871881	120	150	quantitative mass spectrometry	T058	UMLS:C3525763
27871881	151	159	Epilepsy	T038	UMLS:C0014544
27871881	179	208	chronic neurological disorder	T038	UMLS:C1290882
27871881	277	282	human	T204	UMLS:C0086418
27871881	283	293	population	T098	UMLS:C1257890
27871881	299	319	molecular mechanisms	T038	UMLS:C1148560
27871881	323	338	epileptogenesis	T038	UMLS:C0014544
27871881	414	422	epilepsy	T038	UMLS:C0014544
27871881	468	472	care	T058	UMLS:C0086388
27871881	511	516	lipid	T103	UMLS:C0023779
27871881	517	536	signalling pathways	T038	UMLS:C0037080
27871881	540	555	epileptogenesis	T038	UMLS:C0014544
27871881	562	567	lipid	T103	UMLS:C0023779
27871881	568	575	signals	T038	UMLS:C0037080
27871881	596	606	biomarkers	T201	UMLS:C0005516
27871881	648	666	epileptic disorder	T038	UMLS:C0014544
27871881	689	707	therapeutic agents	T103	UMLS:C1611640
27871881	752	761	lipidomic	T103	UMLS:C0023779
27871881	762	770	strategy	T062	UMLS:C0035171
27871881	782	787	lipid	T103	UMLS:C0023779
27871881	803	816	brain regions	T082	UMLS:C1273723
27871881	818	835	periphery tissues	T017	UMLS:C0040300
27871881	840	846	plasma	T031	UMLS:C0032105
27871881	875	893	epileptic seizures	T038	UMLS:C0014544
27871881	897	901	mice	T204	UMLS:C0025929
27871881	914	921	seizure	T038	UMLS:C0014544
27871881	935	943	systemic	T062	UMLS:C3494163
27871881	944	955	kainic acid	T103	UMLS:C0022471
27871881	956	965	injection	T062	UMLS:C3494163
27871881	1036	1049	phospholipids	T103	UMLS:C0031676
27871881	1054	1068	sphingomyelins	T103	UMLS:C0037906
27871881	1079	1095	endocannabinoids	T103	UMLS:C1172779
27871881	1096	1106	anandamide	T103	UMLS:C0211726
27871881	1108	1111	AEA	T103	UMLS:C0211726
27871881	1117	1140	2-arachidonoyl glycerol	T103	UMLS:C0299477
27871881	1142	1146	2-AG	T103	UMLS:C0299477
27871881	1157	1172	endocannabinoid	T103	UMLS:C1172779
27871881	1182	1191	compounds	T103	UMLS:C1706082
27871881	1192	1210	oleoylethanolamide	T103	UMLS:C1454896
27871881	1212	1215	OEA	T103	UMLS:C1454896
27871881	1221	1242	palmitoylethanolamide	T103	UMLS:C0069964
27871881	1244	1247	PEA	T103	UMLS:C0069964
27871881	1256	1272	arachidonic acid	T103	UMLS:C0003695
27871881	1274	1276	AA	T103	UMLS:C0003695
27871881	1293	1304	eicosanoids	T103	UMLS:C0013725
27871881	1314	1324	fatty acyl	T103	UMLS:C0574031
27871881	1336	1344	lipidome	T103	UMLS:C0023779
27871881	1364	1374	pulverized	T062	UMLS:C3494163
27871881	1375	1382	tissues	T017	UMLS:C0459385
27871881	1392	1405	brain regions	T082	UMLS:C1273723
27871881	1409	1420	kainic acid	T103	UMLS:C0022471
27871881	1429	1446	epileptic seizure	T038	UMLS:C0014544
27871881	1476	1488	hypothalamus	T017	UMLS:C0020663
27871881	1490	1501	hippocampus	T017	UMLS:C0019564
27871881	1503	1511	thalamus	T017	UMLS:C0039729
27871881	1513	1521	striatum	T017	UMLS:C0010097
27871881	1523	1533	cerebellum	T017	UMLS:C0007765
27871881	1538	1553	cerebral cortex	T017	UMLS:C0007776
27871881	1564	1574	peripheral	T082	UMLS:C0205100
27871881	1575	1581	organs	T017	UMLS:C0178784
27871881	1591	1596	heart	T017	UMLS:C0018787
27871881	1601	1606	lungs	T017	UMLS:C0024109
27871881	1615	1621	plasma	T031	UMLS:C0032105
27871881	1638	1643	lipid	T103	UMLS:C0023779
27871881	1663	1681	epileptic seizures	T038	UMLS:C0014544
27871881	1735	1747	brain region	T082	UMLS:C1273723
27871881	1754	1770	periphery tissue	T017	UMLS:C0040300
27871881	1802	1808	plasma	T031	UMLS:C0032105
27871881	1809	1814	lipid	T103	UMLS:C0023779
27871881	1855	1872	marker candidates	T201	UMLS:C0005516
27871881	1890	1906	research studies	T062	UMLS:C0681814
27871881	1915	1929	drug discovery	T062	UMLS:C0920472
27871881	1934	1953	response monitoring	T058	UMLS:C0085421